Skip to main content
Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · IEX Real-Time Price · USD
3.250
+0.050 (1.56%)
At close: May 8, 2024, 4:00 PM
3.350
+0.100 (3.08%)
Pre-market: May 9, 2024, 8:13 AM EDT

Turnstone Biologics Revenue

In the year 2023, Turnstone Biologics had annual revenue of $19.31M, a decrease of -73.66%.

Revenue (ttm)
$19.31M
Revenue Growth
-73.66%
P/S Ratio
3.89
Revenue / Employee
$241,325
Employees
80
Market Cap
75.17M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202319.31M-53.99M-73.66%
Dec 31, 202273.30M-27.99M-27.64%
Dec 31, 2021101.29M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

TSBX News

More News